
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Whole-tumor-antigen-pulsed dendritic cells elicit cytotoxic T-cell response against pediatric nasopharyngeal carcinoma in vitro
Yufeng Dou, Guocheng Zhang, XU Dong-liang, et al.
Medical Oncology (2008) Vol. 26, Iss. 1, pp. 78-85
Closed Access | Times Cited: 11
Yufeng Dou, Guocheng Zhang, XU Dong-liang, et al.
Medical Oncology (2008) Vol. 26, Iss. 1, pp. 78-85
Closed Access | Times Cited: 11
Showing 11 citing articles:
Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults
Martina Buehrlen, C. Michel Zwaan, Bernd Granzen, et al.
Cancer (2012) Vol. 118, Iss. 19, pp. 4892-4900
Closed Access | Times Cited: 110
Martina Buehrlen, C. Michel Zwaan, Bernd Granzen, et al.
Cancer (2012) Vol. 118, Iss. 19, pp. 4892-4900
Closed Access | Times Cited: 110
Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma
Chang-Yu Chen, Yung-Song Lin, Chien-Ho Chen, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 65
Chang-Yu Chen, Yung-Song Lin, Chien-Ho Chen, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 65
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
Corey Smith, Victor Lee, Andrea Schuessler, et al.
OncoImmunology (2017) Vol. 6, Iss. 2, pp. e1273311-e1273311
Open Access | Times Cited: 63
Corey Smith, Victor Lee, Andrea Schuessler, et al.
OncoImmunology (2017) Vol. 6, Iss. 2, pp. e1273311-e1273311
Open Access | Times Cited: 63
Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma
Xuan Zhao, Zhen Zhang, Hong Li, et al.
Cancer Letters (2015) Vol. 362, Iss. 2, pp. 192-198
Closed Access | Times Cited: 51
Xuan Zhao, Zhen Zhang, Hong Li, et al.
Cancer Letters (2015) Vol. 362, Iss. 2, pp. 192-198
Closed Access | Times Cited: 51
Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma
Wan Zhang, Zhenghui Song, Jianpeng Xiao, et al.
Journal of Cancer (2019) Vol. 10, Iss. 11, pp. 2578-2587
Open Access | Times Cited: 32
Wan Zhang, Zhenghui Song, Jianpeng Xiao, et al.
Journal of Cancer (2019) Vol. 10, Iss. 11, pp. 2578-2587
Open Access | Times Cited: 32
Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells
Yafeng Wang, Patricia Kunda, Jianwei Lin, et al.
Oncology Reports (2013) Vol. 29, Iss. 5, pp. 1841-1850
Open Access | Times Cited: 35
Yafeng Wang, Patricia Kunda, Jianwei Lin, et al.
Oncology Reports (2013) Vol. 29, Iss. 5, pp. 1841-1850
Open Access | Times Cited: 35
Ex vivo stimulation of murine dendritic cells by an exopolysaccharide from one of the anamorph of Cordyceps sinensis
Dan Song, Jianyu Lin, Fengjiao Yuan, et al.
Cell Biochemistry and Function (2011) Vol. 29, Iss. 7, pp. 555-561
Closed Access | Times Cited: 21
Dan Song, Jianyu Lin, Fengjiao Yuan, et al.
Cell Biochemistry and Function (2011) Vol. 29, Iss. 7, pp. 555-561
Closed Access | Times Cited: 21
Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma
Da‐Yong Cao, Jingyue Yang, Shuqiang Yue, et al.
Cellular Immunology (2009) Vol. 259, Iss. 1, pp. 13-20
Closed Access | Times Cited: 20
Da‐Yong Cao, Jingyue Yang, Shuqiang Yue, et al.
Cellular Immunology (2009) Vol. 259, Iss. 1, pp. 13-20
Closed Access | Times Cited: 20
A CTLA-4 blocking strategy based on Nanobody in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects
Wu Wang, Xi Wang, Wenli Yang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Wu Wang, Xi Wang, Wenli Yang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Autoimmune response induced by dendritic cells exerts anti-tumor effect in murine model of leukemia
Bor‐Yu Tsai, Yu‐Li Lin, Bor‐Luen Chiang
Journal of Autoimmunity (2009) Vol. 34, Iss. 4, pp. 364-370
Closed Access | Times Cited: 5
Bor‐Yu Tsai, Yu‐Li Lin, Bor‐Luen Chiang
Journal of Autoimmunity (2009) Vol. 34, Iss. 4, pp. 364-370
Closed Access | Times Cited: 5
A CTLA-4 Blocking Strategy Based on Nanobaby in Dendritic Cell-stimulated Cytokine-induced Killer Cells Enhances Their Anti-tumor Effects
Wu Wang, Kai Zhong, Xi Wang, et al.
Research Square (Research Square) (2021)
Open Access
Wu Wang, Kai Zhong, Xi Wang, et al.
Research Square (Research Square) (2021)
Open Access